Form 8-K - Current report:
SEC Accession No. 0000950170-24-122244
Filing Date
2024-11-06
Accepted
2024-11-06 16:01:44
Documents
13
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20241106.htm   iXBRL 8-K 41806
2 EX-99.1 acet-ex99_1.htm EX-99.1 142278
3 GRAPHIC img94724212_0.jpg GRAPHIC 2032
  Complete submission text file 0000950170-24-122244.txt   312115

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20241106.xsd EX-101.SCH 25038
16 EXTRACTED XBRL INSTANCE DOCUMENT acet-20241106_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 241430790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)